B6.Cg-Tg(G6PD)#Srn/Cnbc

Status

Available to order

EMMA IDEM:13519
Citation informationRRID:IMSR_EM:13519 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Tg(G6PD)#Srn/Cnbc
Alternative nameG6PD-Tg
Strain typeTransgenic Strains
Allele/Transgene symbolTg(G6PD)#Srn
Gene/Transgene symbolTg(G6PD)#Srn

Information from provider

ProviderManuel Serrano
Provider affiliationCellular Plasticity and Disease, Institute for Research in Biomedicine (IRB)
Genetic informationTransgenic mouse with moderate overexpression of human G6PD under its endogenous promoter.
Phenotypic informationHomozygous:
We never tried to generate homozygous mice.

Heterozygous:
G6PD-Tg mice have constitutively increased levels of PPP activity and thereby higher levels of NADPH. G6PD-Tg mice and cells are partially protected from oxidative damage. G6PD overexpression partially protects from ageing-associated functional decline.
Breeding historyThe founder G6PD-Tg mouse was backcrossed for 6 generations with pure C57BL/6 mice.
References
  • Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.;De la Rosa Adrian, Gomez-Cabrera Mari Carmen, Vinue Angela, Gonzalez-Navarro Herminia, Sanchez-Andres Juan Vicente, Viña Jose, ;2021;Free radical biology & medicine;164;149-153; 33418115
  • G6PD overexpression protects from oxidative stress and age-related hearing loss.;Bermúdez-Muñoz Jose M, Celaya Adelaida M, Hijazo-Pechero Sara, Wang Jing, Serrano Manuel, Varela-Nieto Isabel, ;2020;Aging cell;19;e13275; 33222382
  • G6PD protects from oxidative damage and improves healthspan in mice.;Nóbrega-Pereira Sandrina, Fernandez-Marcos Pablo J, Brioche Thomas, Gomez-Cabrera Mari Carmen, Salvador-Pascual Andrea, Flores Juana M, Viña Jose, Serrano Manuel, ;2016;Nature communications;7;10894; 26976705
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous C57BL/6J males

Literature references

  • Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.;De la Rosa Adrian, Gomez-Cabrera Mari Carmen, Vinue Angela, Gonzalez-Navarro Herminia, Sanchez-Andres Juan Vicente, Viña Jose, ;2021;Free radical biology & medicine;164;149-153; 33418115
  • G6PD overexpression protects from oxidative stress and age-related hearing loss.;Bermúdez-Muñoz Jose M, Celaya Adelaida M, Hijazo-Pechero Sara, Wang Jing, Serrano Manuel, Varela-Nieto Isabel, ;2020;Aging cell;19;e13275; 33222382
  • G6PD protects from oxidative damage and improves healthspan in mice.;Nóbrega-Pereira Sandrina, Fernandez-Marcos Pablo J, Brioche Thomas, Gomez-Cabrera Mari Carmen, Salvador-Pascual Andrea, Flores Juana M, Viña Jose, Serrano Manuel, ;2016;Nature communications;7;10894; 26976705

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).